Mammographic Density and Breast Cancer After Ductal Carcinoma In Situ
- 5 October 2004
- journal article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 96 (19) , 1467-1472
- https://doi.org/10.1093/jnci/djh260
Abstract
Women with ductal carcinoma in situ (DCIS) are at substantially increased risk for a second breast cancer, but few strong predictors for these subsequent tumors have been identified. We used Cox regression modeling to examine the association between mammographic density at diagnosis of DCIS of 504 women from the National Surgical Adjuvant Breast and Bowel Project B-17 trial and risk of subsequent breast cancer events. In this group of patients, mostly 50 years old or older, approximately 6.6% had breasts categorized as highly dense (i.e., > or =75% of the breast occupied by dense tissue). After adjusting for treatment with radiotherapy, age, and body mass index, women with highly dense breasts had 2.8 (95% confidence interval [CI] = 1.3 to 6.1) times the risk of subsequent breast cancer (DCIS or invasive), 3.2 (95% CI = 1.2 to 8.5) times the risk of invasive breast cancer, and 3.0 (95% CI = 1.2 to 7.5) times the risk of any ipsilateral breast cancer, compared with women with less than 25% of the breast occupied by dense tissue. Our results provide initial evidence that the risk of second breast cancers may be increased among DCIS patients with highly dense breasts.Keywords
This publication has 65 references indexed in Scilit:
- Conjugated Equine Estrogen Influence on Mammographic Density in Postmenopausal Women in a Substudy of the Women's Health Initiative Randomized TrialJournal of Clinical Oncology, 2009
- Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidenceBreast Cancer Research, 2008
- Association between Breast Density and Subsequent Breast Cancer Following Treatment for Ductal Carcinoma In situCancer Epidemiology, Biomarkers & Prevention, 2007
- Serum prolactin levels are positively associated with mammographic density in postmenopausal womenBreast Cancer Research and Treatment, 2007
- Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimensClimacteric, 2001
- Effects of Estrogen and Estrogen–Progestin on Mammographic Parenchymal DensityAnnals of Internal Medicine, 1999
- Prostate Cancer--Look to Denmark?JNCI Journal of the National Cancer Institute, 1996
- Quantitative Classification of Mammographic Densities and Breast Cancer Risk: Results From the Canadian National Breast Screening StudyJNCI Journal of the National Cancer Institute, 1995
- Changes in Mammographic Densities Induced by a Hormonal Contraceptive Designed to Reduce Breast Cancer RiskJNCI Journal of the National Cancer Institute, 1994
- Mammary Gland Mass and Breast Cancer RiskEpidemiology, 1992